Alcohol Use Disorder (AUD)RISENCT07217795
Recovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building
A study testing CBT + expressive writing in people with Alcohol Use Disorder (AUD) and PTSD, run by University of Rhode Island at 1 site in United States.
Trial summary
This is a two-part study to develop and test a brief, virtual therapy program for lesbian, gay, bisexual, transgender, and queer (LGBTQ+) people who have experienced trauma and use alcohol. Phase 1: You'll be invited to share your perspective to help make the program relevant, inclusive, and affirming. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Alcohol Use Disorder (AUD), PTSD
- What is being tested?
- CBT + expressive writing
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 80 participants
- Where
- 1 siteUnited States
- Study dates
- 30 Nov 2025to Sep 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Aim 1: Sexual Minority Women and Transgender and Gender Diverse Individuals -Not meeting inclusion criteria
Aim 1: Providers
-Not meeting inclusion criteria
Aim 2: Sexual Minority Women and Transgender and Gender Diverse Individuals
- Not meeting inclusion criteria OR any of the following:
- Reporting current mental health treatment ≥1 day/month
- Receiving Cognitive Behavioral Therapy (CBT) in the past 3 months (note: participants are not ineligible if they seek concomitant care after enrollment)
- Reporting current alcohol or drug use disorder treatment, except mutual self-help (e.g., Alcoholics Anonymous) or current PTSD/trauma-focused treatment
- Need for alcohol detoxification, defined as score ≥15 on the adapted self-report Clinical Institute Withdrawal Assessment for Alcohol - Revised (CIWA-Ar)
- Active psychosis, defined as score ≥1 on the psychosis subscale of the Behavior and Symptom Identification Scale - Revised (BASIS-R)
- Active mania, defined as score ≥6 on the Altman Self-Rating Mania Scale (ASRM)
- Active suicidality, defined as score ≥22 on the Suicidal Ideation Attributes Scale (SIDAS)
- Currently legally mandated to attend treatment
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
University of Rhode Island
Providence, Rhode Island, 02860
Jillian Scheer, PhD, 401.874.2193, jillian.scheer@uri.edu
About this study
Official title: Developing a Telehealth Intervention for Alcohol and Trauma Among LGBTQ+ People
This is a two-part study to develop and test a brief, virtual therapy program for lesbian, gay, bisexual, transgender, and queer (LGBTQ+) people who have experienced trauma and use alcohol.
Phase 1: You'll be invited to share your perspective to help make the program relevant, inclusive, and affirming.
Phase 2: You may have the opportunity to try the adapted program by receiving free virtual therapy with LGBTQ+-affirming therapists.
- Conditions
- Alcohol Use Disorder (AUD), PTSD
- Being tested
- CBT + expressive writing, Wait-List Control
- Keywords
- LGBTQ, cognitive behavioral therapy, expressive writing, PTSD, alcohol use, telehealth
- Medical subject headings
- Alcoholism, Stress Disorders, Post-Traumatic, Alcohol Drinking
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
CBT + expressive writingBehavioural
This study will test a remotely delivered intervention combining Cognitive Behavioral Therapy (CBT) and Expressive Writing (EW) to address unhealthy alcohol use and traumatic stress among sexual minority women (SMW; e.g., lesbian, bisexual women) and transgender and gender-diverse (TGD) individuals. The intervention, called Recovery through Inhibitory Learning, Self-Efficacy Building, Problem-Solving, and Community Building (RISE), integrates CBT modules on assertiveness, problem-solving in high-risk situations, and building social connections with a brief EW program tailored to SMW and TGD participants. Four modules from the Unified Protocol (UP), a transdiagnostic CBT approach, will be adapted: (1) psychoeducation, goal setting, and motivational enhancement; (2) mindful emotional awareness; (3) cognitive flexibility; and (4) countering emotion-driven behaviors.
Wait-List ControlBehavioural
Participants assigned to the wait-list will not receive active treatment during the study period but will be offered the RISE intervention afterward.
| Study group | Role | What they receive |
|---|---|---|
| RISE | Experimental | Description: Participants receive the RISE intervention, a remotely delivered CBT + Expressive Writing program.
Intervention: Behavioral: RISE (CBT + Expressive Writing) Receives: Behavioral: CBT + expressive writing |
| Control: Wait-List Control | Other | Participants are placed on a wait-list and offered the RISE intervention after the study period. Receives: Behavioral: Wait-List Control |
What is being measured
The primary outcome is the main question the study is designed to answer.
Posttraumatic Stress Disorder Diagnosis and Severity using the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5)
Posttraumatic Stress Disorder (PTSD) will be assessed using the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5), a clinician-administered interview that evaluates Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) PTSD criteria. It provides both a total severity score (0-80) and a dichotomous diagnosis (present/absent).
Units of Measure: Total score (0-80); diagnosis status (yes/no)
Measured: Baseline: Past 30 days 1-week Follow-up: Past 1 week
Posttraumatic Stress Disorder Symptom Severity using the PTSD Checklist for DSM-5 (PCL-5)
Posttraumatic Stress Disorder (PTSD) symptom severity will be assessed using the PTSD Checklist for DSM-5 (PCL-5), a 20-item self-report measure. Items are rated on a 5-point Likert scale from 0 ("Not at all") to 4 ("Extremely"), with a total score range of 0-80; higher scores indicate greater PTSD symptom severity. A score of 33 or higher suggests probable PTSD. Units of Measure: Total score (0-80).
Measured: Baseline: Past 30 days 1-week Follow-up: Past 1 week
Hazardous drinking levels
Structured Clinical Interview for DSM-5 - Substance Use Disorders Module (SCID-5-SUD)
Description: Structured Clinical Interview for DSM-5 - Substance Use Disorders Module (SCID-5-SUD) will be used to assess the presence and severity of substance use disorders (SUDs). The SCID-5-SUD is a semi-structured clinical interview administered by trained personnel to determine whether a participant meets Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) diagnostic criteria for a substance use disorder (e.g., alcohol, cannabis, opioids, stimulants). For each substance, the SCID-5-SUD evaluates 11 diagnostic criteria, including impaired control, social impairment, risky use, and pharmacological indicators. Severity is categorized based on the number of criteria endorsed: mild (2-3), moderate (4-5), or severe (6 or more).
Units of Measure: Dichotomous diagnosis status (yes/no); severity level (mild, moderate, severe) if applicable
Measured: Baseline: Past 3 months 1-week Follow-up: Past 1 week
Change in average weekly drinking quantity
The Timeline Followback (TLFB) method will be used to assess daily alcohol consumption over the past 30 days. Participants report the number of standard drinks consumed each day, using a calendar-assisted structured interview format. Data are used to calculate total number of drinking days, total drinks consumed, average drinks per drinking day, and number of heavy drinking days (4+ drinks for women, 5+ for men). This measure provides a reliable estimate of recent alcohol use patterns and is widely used in clinical and research settings.
Units of Measure: Number of drinking days, total drinks, drinks per drinking day,
Measured: Baseline: Past 30 days 1-week Follow-up: Past 1 week
Change in heavy drinking frequency
Description: Alcohol use will be assessed using a six-item self-report measure evaluating past-week drinking frequency, quantity, and risky use. Items include: frequency of drinking (scored 0-6), maximum number of drinks in 24 hours (scored 1-10), typical number of drinks per drinking day (scored 1-10), total number of drinks per week (scored 1-11), and frequency of binge drinking (defined as 4 or more drinks in one occasion) and high-intensity drinking (defined as 8 or more drinks in one occasion), both scored 0-6.
In addition, the Timeline Followback (TLFB) method will be used to assess daily alcohol use over the past 30 days. The TLFB captures number of drinking days, total number of drinks, average drinks per drinking day, and number of heavy drinking days.
Units of Measure: Item scores range 0-6, 1-10, or 1-11; TLFB outcomes include days and number of drinks.
Measured: Baseline: Past 30 days 1-week Follow-up: Past 1 week
Secondary outcomes (26)
Depression symptoms
Title: Depression Severity and Impairment (ODSIS)
Description:
The Overall Depression Severity and Impairment Scale (ODSIS) is a 5-item self-report measure assessing the frequency and intensity of depressive symptoms, as well as related distress and functional impairment. Each item is rated on a 0-4 scale, with total scores ranging from 0 to 20. Higher scores indicate greater severity of depression and impairment. The ODSIS is sensitive to clinical change and has strong psychometric properties.
Units of Measure: Total score (0-20)
Measured: Baseline: Past 1 week 1-week Follow-up: Past 1 week
Anxiety symptoms
Title: Anxiety Severity and Impairment (OASIS) Description: The Overall Anxiety Severity and Impairment Scale (OASIS) is a 5-item self-report measure assessing the frequency and intensity of anxiety symptoms, as well as related avoidance, distress, and functional impairment. Each item is rated on a 0-4 scale, with total scores ranging from 0 to 20. Higher scores indicate greater anxiety severity and impairment. The OASIS is brief, transdiagnostic, and sensitive to treatment-related change.
Units of Measure: Total score (0-20)
Measured: Baseline: Past 1 week 1-week Follow-up: Past 1 week
Perceived Stress
Title: Perceived Stress (PSS-10)
Description: The Perceived Stress Scale-10 (PSS-10) is a 10-item self-report measure that assesses the degree to which individuals perceive their life situations as stressful over the past month. Each item is rated on a 0-4 scale, with total scores ranging from 0 to 40. Higher scores indicate greater perceived stress. The PSS-10 is widely used and has demonstrated strong reliability and validity across populations.
Units of Measure: Total score (0-40)
Measured: Baseline: Past 30 days 1-week Follow-up: Past 1 week
Suicidality
Title: Suicidal Ideation Attributes Scale (SIDAS) Description: The Suicidal Ideation Attributes Scale (SIDAS) is a 5-item self-report measure assessing the severity of suicidal thoughts over the past 30 days, including frequency, controllability, closeness to attempt, associated distress, and functional interference. Each item is rated on a 0-10 scale, with total scores ranging from 0 to 50. Higher scores indicate more severe suicidal ideation. A score of 21 or above indicates high risk and warrants clinical attention.
Units of Measure: Total score (0-50)
Measured: Baseline: Past 30 days 1-week Follow-up: Past 1 week
Readiness to change
Title: Readiness to Change Alcohol Use (Readiness Ruler)
Description: The Readiness Ruler is a single-item self-report measure assessing how ready a person feels to change their alcohol use. Participants rate their readiness on a scale from 0 ("not at all ready") to 10 ("completely ready"). Higher scores indicate greater motivation to change drinking behavior. This tool is commonly used in brief interventions and motivational interviewing.
Units of Measure: Score (0-10)
Measured: Baseline: At baseline assessment 1-week Follow-up: At 1-week follow-up assessment
Change in maximum number of drinks on any day
Title: Maximum Drinks in a 24-Hour Period (Past Week) Description: This single-item self-report measure assesses the maximum number of alcoholic drinks consumed within a 24-hour period during the past week. Participants select one of 10 ordinal response options ranging from 1 ("1 drink") to 10 ("36 drinks or more"). Higher scores reflect greater peak alcohol consumption.
Units of Measure: Score (1-10)
Measured: Baseline: Past 30 days 1-week Follow-up: Past 1 week
Alcohol-related consequences
Title: Alcohol-Related Consequences (Short Inventory of Problems-2R)
Description: The Short Inventory of Problems-2R (SIP-2R) is a 15-item self-report measure assessing adverse consequences of alcohol use across five domains: physical, interpersonal, intrapersonal, impulse control, and social responsibility. Items are rated based on how often each consequence occurred in the past 3 months using a 4-point scale from 0 ("never") to 3 ("daily or almost daily"). Total scores range from 0 to 45, with higher scores indicating greater alcohol-related problems.
Units of Measure: Total score (0-45)
Measured: Baseline: Past 90 days 1-week Follow-up: Past 1 week
Alcohol craving
Title: Alcohol-Related Consequences (Short Inventory of Problems-2R)
Description: The Short Inventory of Problems-2R (SIP-2R) is a 15-item self-report questionnaire measuring negative consequences of alcohol use over the past 3 months across five domains: physical, interpersonal, intrapersonal, impulse control, and social responsibility. Each item is rated on a 4-point scale from 0 ("never") to 3 ("daily or almost daily"). Total scores range from 0 to 45, with higher scores indicating more frequent or severe alcohol-related problems.
Units of Measure: Total score (0-45)
Measured: Baseline: Past 1 week 1-week Follow-up: Past 1 week
Alexithymia
Title: Alexithymia Severity (Perth Alexithymia Questionnaire)
Description: Alexithymia will be assessed using the 24-item Perth Alexithymia Questionnaire (PAQ), a self-report measure evaluating difficulties identifying and describing feelings across positive and negative emotions. The focus will be on the negative-difficulty identifying feelings and negative-difficulty describing feelings subscales. Items are rated on a 7-point Likert scale from 1 ("Strongly disagree") to 7 ("Strongly agree"). Higher scores indicate greater alexithymia. Total and subscale scores will be calculated by summing relevant items.
Units of Measure: Total and subscale scores (higher scores indicate greater alexithymia)
Measured: Baseline: At baseline assessment 1-week Follow-up: At 1-week follow-up assessment
Anxiety sensitivity
Title: Anxiety Sensitivity (SSASI)
Description: Anxiety sensitivity will be assessed using the Short Scale Anxiety Sensitivity Index (SSASI), a 5-item self-report measure evaluating concerns about the physical, cognitive, and social consequences of anxiety-related sensations. Items include fears of bodily sensations, cognitive control, and social evaluation (e.g., "When I tremble in the presence of others, I fear what people might think of me"). Each item is rated on a 5-point scale from 0 ("very little") to 4 ("very much"). Total scores are calculated by summing all items, with higher scores indicating greater anxiety sensitivity.
Units of Measure: Total score (0-20)
Measured: Baseline: At baseline assessment 1-week Follow-up: At 1-week follow-up assessment
Negative emotionality
Title: Negative Emotionality Big Five Inventory-2 (BFI-2)
Description: Negative emotionality will be assessed using the Big Five Inventory-2 (BFI-2) self-report form. Participants rate 12 items describing emotional tendencies (e.g., mood swings, worry, sadness) on a 5-point scale from 1 ("disagree strongly") to 5 ("agree strongly"). Reverse-scored items (r) are included to assess emotional stability. Subscale and total negative emotionality scores are calculated as the mean of relevant items, with higher scores indicating greater negative emotionality.
Units of Measure: Mean score (1-5)
Measured: Baseline: At baseline assessment 1-week Follow-up: At 1-week follow-up assessment
Posttraumatic maladaptive beliefs scale
Title: Posttraumatic Maladaptive Beliefs (PMBS)
Description: Posttraumatic beliefs will be assessed using the Posttraumatic Maladaptive Beliefs Scale (PMBS), a self-report measure evaluating negative cognitions and beliefs following trauma. Items assess domains such as self-blame, mistrust of others, and perceptions of threat or vulnerability. Participants rate each item on a Likert scale (e.g., 1 = "strongly disagree" to 5 = "strongly agree"), with higher scores indicating more maladaptive posttraumatic beliefs. Total and subscale scores can be calculated to assess the severity and domain-specific patterns of trauma-related cognitions.
Units of Measure: Total and subscale scores (higher scores indicate greater maladaptive beliefs)
Measured: Baseline: At baseline assessment 1-week Follow-up: At 1-week follow-up assessment
Dissociation
Title: Dissociative Experiences Brief Dissociative Experiences Scale-B (DES-B Modified)
Description: Dissociative experiences will be assessed using the 8-item Modified Brief Dissociative Experiences Scale (DES-B). Participants rate each item based on experiences over the past 7 days, using a 5-point scale: 0 = "Not at all," 1 = "Once or twice," 2 = "Almost every day," 3 = "About once a day," and 4 = "More than once a day." Total scores range from 0 to 32, with higher scores indicating greater severity. An average total score is calculated by dividing the total score by 8, yielding a 0-4 scale corresponding to none, mild, moderate, severe, or extreme dissociation.
Units of Measure: Total score (0-32) and average score (0-4)
Measured: Baseline: Past 1-week 1-week Follow-up: Past 1-week
Brief experiential avoidance questionarraire
Title: Experiential Avoidance Brief Experiential Avoidance Questionnaire (BEAQ)
Description: Experiential avoidance will be assessed using the Brief Experiential Avoidance Questionnaire (BEAQ), a self-report measure evaluating the tendency to avoid or escape unwanted internal experiences. Participants rate items on a 6-point scale from 1 ("strongly disagree") to 6 ("strongly agree"). Item 6 is reverse-scored, and total scores are calculated by summing all items, with higher scores indicating greater experiential avoidance.
Units of Measure: Total score (sum of items; higher scores indicate greater avoidance)
Measured: Baseline: At baseline assessment 1-week Follow-up: At 1-week follow-up assessment
Coping
Title: Coping Strategies (Brief Coping Orientation to Problems Experienced [COPE])
Description: Coping strategies will be assessed using the Brief Coping Orientation to Problems Experienced (COPE), a 28-item self-report measure evaluating how individuals respond to stressors over the past 30 days. Items are rated on a 4-point scale: 1 = "I haven't been doing this at all," 2 = "I've been doing this a little bit," 3 = "I've been doing this a medium amount," and 4 = "I've been doing this a lot." Subscale scores are calculated as the mean of two items per subscale, including indicators of avoidance coping (self-distraction, denial, behavioral disengagement) and other coping strategies. Higher scores indicate greater use of the specific coping strategy.
Units of Measure: Mean subscale scores (1-4)
Measured: Baseline: At baseline assessment 1-week Follow-up: At 1-week follow-up assessment
Emotion regulation
Title: Emotion Regulation Difficulties Short Form (Difficulties in Emotion Regulation Scale Short Form [DERS-SF])
Description: Emotion regulation difficulties will be assessed using the Difficulties in Emotion Regulation Scale Short Form (DERS-SF), an 18-item self-report measure evaluating challenges in managing emotions, including nonacceptance of emotional responses and difficulties engaging in goal-directed behavior. Items are rated on a 5-point scale from 1 ("almost never") to 5 ("almost always"), with the acceptance items reverse-scored. Mean scores are calculated, with higher scores indicating greater difficulties in emotion regulation.
Units of Measure: Mean score (1-5)
Measured: Baseline: At baseline assessment 1-week Follow-up: At 1-week follow-up assessment
Self-Compassion
Title: Self-Compassion Scale (SCS - Self-Kindness, Common Humanity, Mindfulness Subscales)
Description: Self-compassion will be assessed using the Self-Compassion Scale (SCS), focusing on the self-kindness, common humanity, and mindfulness subscales. Participants rate items on a 5-point scale from 1 ("almost never") to 5 ("almost always"), indicating how often they engage in the behaviors described. Mean scores are calculated for each subscale, with higher scores reflecting greater self-compassion.
Units of Measure: Mean score (1-5)
Measured: Baseline: At baseline assessment 1-week Follow-up: At 1-week follow-up assessment
Loneliness
Title: Loneliness (University of California, Los Angeles [UCLA] Loneliness Scale - Short Form)
Description: Loneliness will be assessed using the 3-item short form of the UCLA Loneliness Scale. Participants indicate how often they experience feelings of lacking companionship, feeling left out, or feeling isolated from others. Items are rated on a 4-point Likert scale: 1 = "Never," 2 = "Rarely," 3 = "Sometimes," and 4 = "Often."
Units of Measure: Total score (range: 3-12), with higher scores indicating greater loneliness.
Measured: Baseline: At baseline assessment 1-week Follow-up: At 1-week follow-up assessment
Social support
Title: Perceived Social Support (Multidimensional Scale of Perceived Social Support [MSPSS])
Description: Perceived social support will be assessed using the Multidimensional Scale of Perceived Social Support (MSPSS), a 12-item self-report measure evaluating support from family, friends, and a significant other. Items are rated on a 7-point scale from 1 ("Very Strongly Disagree") to 7 ("Very Strongly Agree"). Total scores are calculated by summing all items, with higher scores indicating greater perceived social support. Subscale scores can also be calculated for each support source.
Units of Measure: Total score (12-84) and subscale scores
Measured: Baseline: At baseline assessment 1-week Follow-up: At 1-week follow-up assessment
LGBTQ+ Community connection
Title: LGBTQ+ Community Connection (Lesbian, Gay, Bisexual Positive Identity Measure [LGB-PIM])
Description: Connection to the LGBTQ+ community will be assessed using the 5-item LGBTQ+ Community Connection subscale of the Lesbian, Gay, Bisexual Positive Identity Measure (LGB-PIM). Items assess feelings of support, visibility, inclusion, connection, and positive networking within the LGBTQ+ community. Participants rate each item on a 7-point scale from 1 ("Strongly Disagree") to 7 ("Strongly Agree"). Mean scores are calculated, with higher scores indicating stronger perceived connection to the LGBTQ+ community.
Units of Measure: Mean score (1-7)
Measured: Baseline: At baseline assessment 1-week Follow-up: At 1-week follow-up assessment
Positive and Negative Affect
Title: Positive and Negative Affect (PANAS)
Description: Mood will be assessed using the 10-item Positive and Negative Affect Schedule (PANAS), past-week version. Participants rate the extent to which they have experienced various positive and negative emotions (e.g., distressed, nervous, irritable) over the past 7 days. Items are rated on a 5-point scale, with higher mean scores indicating greater levels of positive or negative affect. Separate mean scores are calculated for the positive affect and negative affect scales.
Units of Measure: Mean score (1-5) for positive affect and negative affect
Measured: Baseline: Past 4 weeks 1-week Follow-up: Past 1 week
Physical health
Title: Physical Health (World Health Organization Quality of Life-BREF [WHOQOL-BREF])
Description: Physical health will be assessed using the World Health Organization Quality of Life-BREF (WHOQOL-BREF) physical health item. Participants rate the extent to which physical pain has interfered with their ability to perform daily activities over the past week. Items are rated on a 5-point scale: 1 = "Not at all," 2 = "A little," 3 = "A moderate amount," 4 = "Very much," 5 = "An extreme amount." Negatively framed items are reverse-scored, and total or summed scores reflect better physical health when higher.
Units of Measure: Summed score (1-5 per item)
Measured: Baseline: Past 2 weeks 1-week Follow-up: Past 1 week
LGBTQ-Hypervigilance
Title: LGBTQ+ Hypervigilance
Description: Hypervigilance related to LGBTQ+ identity will be assessed using the LGBTQ-Hypervigilance Scale, a self-report measure evaluating heightened alertness or vigilance in public or social settings. Participants rate each item based on experiences in the past week on a 7-point scale from 1 ("Strongly Disagree") to 7 ("Strongly Agree"), with higher scores indicating greater hypervigilance.
Units of Measure: Total score or mean item score (higher scores indicate greater LGBTQ+ hypervigilance)
Measured: Baseline: Past 12 months 1-week Follow-up: Past 1 week
Lesbian, Gay, Bisexual Identity Scale
Title: Sexual Minority Identity (Lesbian, Gay, Bisexual Identity Scale - Internalized Homonegativity \& Concealment Motivation)
Description: Sexual minority identity will be assessed using the Lesbian, Gay, and Bisexual Identity Scale (LGBIS), focusing on the Internalized Homonegativity (IH) and Concealment Motivation (CM) subscales. Participants rate items on a 6-point scale from 1 ("Disagree strongly") to 6 ("Agree strongly") reflecting their current experiences as a sexual minority. Subscale scores are calculated by averaging relevant items, with higher scores indicating greater internalized homonegativity or stronger motivation to conceal one's sexual orientation.
Units of Measure: Mean subscale scores (1-6)
Measured: Baseline: At baseline assessment 1-week Follow-up: At 1-week follow-up assessment
Cannabis use
Title: Cannabis Use (Cannabis Use Disorder Identification Test - Revised [CUDIT-R])
Description:
Cannabis use over the past week will be assessed using a single item from the Cannabis Use Disorder Identification Test - Revised (CUDIT-R). Participants indicate whether they have used cannabis in the past 7 days. Responses are coded as 1 = "Yes" and 0 = "No."
Units of Measure: Binary (Yes = 1, No = 0)
Measured: Baseline: Past 3 months 1-week Follow-up: Past 1 week
Other drug use
Title: Past-Week Substance Use (National Survey on Drug Use and Health [NSDUH])
Description: Past-week substance use will be assessed using items adapted from the 2020 National Survey on Drug Use and Health (NSDUH). Participants report: (1) the number of days they smoked cigarettes in the past 7 days (0-30), and (2) the average number of cigarettes smoked per day on those days (coded 1-7: less than 1, 1, 2-5, 6-15, 16-25, 26-35, more than 35). Participants also report the number of days they used other illicit drugs or misused prescription drugs in the past week (0-30 days). Higher values indicate greater substance use.
Units of Measure: Number of days (0-30) for each substance; average cigarettes per day (1-7)
Measured: Baseline: Past 1 month 1-week Follow-up: Past 1 week
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Oct 2025
- Study start30 Nov 2025
- Primary completionNov 2026 (estimated)
- Study completionSep 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Alcohol Use Disorder (AUD)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- The overall objective of this project is to adapt and pilot test a remotely delivered alcohol-focused cognitive behavioral therapy (CBT) intervention and trauma-focused expressive writing (EW) intervention addressing social determinants of unhealthy alcohol use and traumatic stress among sexual minority women (SMW; e.g., lesbian, bisexual) and transgender and gender-diverse (TGD) people. The Recovery through Inhibitory Learning, Self-Efficacy Building, Problem-Solving, and Community Building (RISE) intervention will integrate adapted CBT modules on assertiveness, problem-solving in high-risk situations, and connecting with others-shown to reduce unhealthy alcohol use-with a brief EW intervention tailored to SMW and TGD people. The four specific Unified Protocol (CBT) modules that will be adapted for the current study are 1) Psychoeducation, goal setting, motivational enhancement; 2) Mindful emotional awareness; 3) Cognitive flexibility; and 4) Countering emotional-driven behaviors.
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 80 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Rhode Island
- Sponsor type
- University, hospital or other
- Collaborators
- Rhode Island Foundation
- Responsible party
- Principal investigator, Jillian Scheer, University of Rhode Island
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07217795
- Sponsor's protocol ID
- 2310793
- Acronym
- RISE
- Status last verified
- Dec 2025
- First submitted
- 12 Aug 2025
- Last updated
- 9 Dec 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Data from this study will not be shared due to the sensitive nature of the information collected and the pilot status of the project. Additionally, data sharing is not required by the study's funder.
Publications
Jaipuriyar V, Behari K, Rashkovsky K, Girard R, Sherman AL, Chasten N, Epshteyn GG, Lee J, Helminen EC, Scheer JR. Brief transdiagnostic cognitive behavioral therapy and expressive writing for hazardous drinking and posttraumatic stress symptoms among sexual and gender minority adults: Pilot trial protocol. Contemp Clin Trials Commun. 2026 Jun 27;52:101666. doi: 10.1016/j.conctc.2026.101666. eCollection 2026 Aug.
PubMed 42404370
Study at a glance
From the registry record, last updated by the sponsor on 9 Dec 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Developing a Telehealth Intervention for Alcohol and Trauma Among LGBTQ+ People
- ClinicalTrials.gov ID
- NCT07217795
- Acronym / sponsor ID
- RISE / 2310793
- Conditions
- Alcohol Use Disorder (AUD), PTSD
- Keywords
- LGBTQ, cognitive behavioral therapy, expressive writing, PTSD, alcohol use, telehealth
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 80 participants (estimated)
- Lead sponsor
- University of Rhode IslandUniversity, hospital or other
- Collaborators
- Rhode Island Foundation
- Study start
- 30 Nov 2025 (actual)
- Primary completion
- Nov 2026 (estimated)
- Study completion
- Sep 2028 (estimated)
- First posted
- 16 Oct 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is a two-part study to develop and test a brief, virtual therapy program for lesbian, gay, bisexual, transgender, and queer (LGBTQ+) people who have experienced trauma and use alcohol.
Phase 1: You'll be invited to share your perspective to help make the program relevant, inclusive, and affirming.
Phase 2: You may have the opportunity to try the adapted program by receiving free virtual therapy with LGBTQ+-affirming therapists.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
- Model description
- The overall objective of this project is to adapt and pilot test a remotely delivered alcohol-focused cognitive behavioral therapy (CBT) intervention and trauma-focused expressive writing (EW) intervention addressing social determinants of unhealthy alcohol use and traumatic stress among sexual minority women (SMW; e.g., lesbian, bisexual) and transgender and gender-diverse (TGD) people. The Recovery through Inhibitory Learning, Self-Efficacy Building, Problem-Solving, and Community Building (RISE) intervention will integrate adapted CBT modules on assertiveness, problem-solving in high-risk situations, and connecting with others-shown to reduce unhealthy alcohol use-with a brief EW intervention tailored to SMW and TGD people. The four specific Unified Protocol (CBT) modules that will be adapted for the current study are 1) Psychoeducation, goal setting, motivational enhancement; 2) Mindful emotional awareness; 3) Cognitive flexibility; and 4) Countering emotional-driven behaviors.
| Arm | Type | Receives |
|---|---|---|
| RISE | Experimental | Behavioral: CBT + expressive writingDescription: Participants receive the RISE intervention, a remotely delivered CBT + Expressive Writing program. Intervention: Behavioral: RISE (CBT + Expressive Writing) |
| Control: Wait-List Control | Other | Behavioral: Wait-List ControlParticipants are placed on a wait-list and offered the RISE intervention after the study period. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| CBT + expressive writingThis study will test a remotely delivered intervention combining Cognitive Behavioral Therapy (CBT) and Expressive Writing (EW) to address unhealthy alcohol use and traumatic stress among sexual minority women (SMW; e.g., lesbian, bisexual women) and transgender and gender-diverse (TGD) individuals. The intervention, called Recovery through Inhibitory Learning, Self-Efficacy Building, Problem-Solving, and Community Building (RISE), integrates CBT modules on assertiveness, problem-solving in high-risk situations, and building social connections with a brief EW program tailored to SMW and TGD participants. Four modules from the Unified Protocol (UP), a transdiagnostic CBT approach, will be adapted: (1) psychoeducation, goal setting, and motivational enhancement; (2) mindful emotional awareness; (3) cognitive flexibility; and (4) countering emotion-driven behaviors. | Behavioural | RISE |
| Wait-List ControlParticipants assigned to the wait-list will not receive active treatment during the study period but will be offered the RISE intervention afterward. | Behavioural | Control: Wait-List Control |
Primary outcome
Posttraumatic Stress Disorder Diagnosis and Severity using the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5)
Time frame: Baseline: Past 30 days 1-week Follow-up: Past 1 week
Posttraumatic Stress Disorder (PTSD) will be assessed using the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5), a clinician-administered interview that evaluates Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) PTSD criteria. It provides both a total severity score (0-80) and a dichotomous diagnosis (present/absent). Units of Measure: Total score (0-80); diagnosis status (yes/no)
Posttraumatic Stress Disorder Symptom Severity using the PTSD Checklist for DSM-5 (PCL-5)
Time frame: Baseline: Past 30 days 1-week Follow-up: Past 1 week
Posttraumatic Stress Disorder (PTSD) symptom severity will be assessed using the PTSD Checklist for DSM-5 (PCL-5), a 20-item self-report measure. Items are rated on a 5-point Likert scale from 0 ("Not at all") to 4 ("Extremely"), with a total score range of 0-80; higher scores indicate greater PTSD symptom severity. A score of 33 or higher suggests probable PTSD. Units of Measure: Total score (0-80).
Hazardous drinking levels
Time frame: Baseline: Past 3 months 1-week Follow-up: Past 1 week
Structured Clinical Interview for DSM-5 - Substance Use Disorders Module (SCID-5-SUD) Description: Structured Clinical Interview for DSM-5 - Substance Use Disorders Module (SCID-5-SUD) will be used to assess the presence and severity of substance use disorders (SUDs). The SCID-5-SUD is a semi-structured clinical interview administered by trained personnel to determine whether a participant meets Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) diagnostic criteria for a substance use disorder (e.g., alcohol, cannabis, opioids, stimulants). For each substance, the SCID-5-SUD evaluates 11 diagnostic criteria, including impaired control, social impairment, risky use, and pharmacological indicators. Severity is categorized based on the number of criteria endorsed: mild (2-3), moderate (4-5), or severe (6 or more). Units of Measure: Dichotomous diagnosis status (yes/no); severity level (mild, moderate, severe) if applicable
Change in average weekly drinking quantity
Time frame: Baseline: Past 30 days 1-week Follow-up: Past 1 week
The Timeline Followback (TLFB) method will be used to assess daily alcohol consumption over the past 30 days. Participants report the number of standard drinks consumed each day, using a calendar-assisted structured interview format. Data are used to calculate total number of drinking days, total drinks consumed, average drinks per drinking day, and number of heavy drinking days (4+ drinks for women, 5+ for men). This measure provides a reliable estimate of recent alcohol use patterns and is widely used in clinical and research settings. Units of Measure: Number of drinking days, total drinks, drinks per drinking day,
Change in heavy drinking frequency
Time frame: Baseline: Past 30 days 1-week Follow-up: Past 1 week
Description: Alcohol use will be assessed using a six-item self-report measure evaluating past-week drinking frequency, quantity, and risky use. Items include: frequency of drinking (scored 0-6), maximum number of drinks in 24 hours (scored 1-10), typical number of drinks per drinking day (scored 1-10), total number of drinks per week (scored 1-11), and frequency of binge drinking (defined as 4 or more drinks in one occasion) and high-intensity drinking (defined as 8 or more drinks in one occasion), both scored 0-6. In addition, the Timeline Followback (TLFB) method will be used to assess daily alcohol use over the past 30 days. The TLFB captures number of drinking days, total number of drinks, average drinks per drinking day, and number of heavy drinking days. Units of Measure: Item scores range 0-6, 1-10, or 1-11; TLFB outcomes include days and number of drinks.
26 secondary outcomes
Depression symptoms
Time frame: Baseline: Past 1 week 1-week Follow-up: Past 1 week
Anxiety symptoms
Time frame: Baseline: Past 1 week 1-week Follow-up: Past 1 week
Perceived Stress
Time frame: Baseline: Past 30 days 1-week Follow-up: Past 1 week
Suicidality
Time frame: Baseline: Past 30 days 1-week Follow-up: Past 1 week
Readiness to change
Time frame: Baseline: At baseline assessment 1-week Follow-up: At 1-week follow-up assessment
Change in maximum number of drinks on any day
Time frame: Baseline: Past 30 days 1-week Follow-up: Past 1 week
Alcohol-related consequences
Time frame: Baseline: Past 90 days 1-week Follow-up: Past 1 week
Alcohol craving
Time frame: Baseline: Past 1 week 1-week Follow-up: Past 1 week
Alexithymia
Time frame: Baseline: At baseline assessment 1-week Follow-up: At 1-week follow-up assessment
Anxiety sensitivity
Time frame: Baseline: At baseline assessment 1-week Follow-up: At 1-week follow-up assessment
Negative emotionality
Time frame: Baseline: At baseline assessment 1-week Follow-up: At 1-week follow-up assessment
Posttraumatic maladaptive beliefs scale
Time frame: Baseline: At baseline assessment 1-week Follow-up: At 1-week follow-up assessment
Dissociation
Time frame: Baseline: Past 1-week 1-week Follow-up: Past 1-week
Brief experiential avoidance questionarraire
Time frame: Baseline: At baseline assessment 1-week Follow-up: At 1-week follow-up assessment
Coping
Time frame: Baseline: At baseline assessment 1-week Follow-up: At 1-week follow-up assessment
Emotion regulation
Time frame: Baseline: At baseline assessment 1-week Follow-up: At 1-week follow-up assessment
Self-Compassion
Time frame: Baseline: At baseline assessment 1-week Follow-up: At 1-week follow-up assessment
Loneliness
Time frame: Baseline: At baseline assessment 1-week Follow-up: At 1-week follow-up assessment
Social support
Time frame: Baseline: At baseline assessment 1-week Follow-up: At 1-week follow-up assessment
LGBTQ+ Community connection
Time frame: Baseline: At baseline assessment 1-week Follow-up: At 1-week follow-up assessment
Positive and Negative Affect
Time frame: Baseline: Past 4 weeks 1-week Follow-up: Past 1 week
Physical health
Time frame: Baseline: Past 2 weeks 1-week Follow-up: Past 1 week
LGBTQ-Hypervigilance
Time frame: Baseline: Past 12 months 1-week Follow-up: Past 1 week
Lesbian, Gay, Bisexual Identity Scale
Time frame: Baseline: At baseline assessment 1-week Follow-up: At 1-week follow-up assessment
Cannabis use
Time frame: Baseline: Past 3 months 1-week Follow-up: Past 1 week
Other drug use
Time frame: Baseline: Past 1 month 1-week Follow-up: Past 1 week
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Dec 2025.
- Derived from this study: PubMed 42404370Jaipuriyar V, Behari K, Rashkovsky K, Girard R, Sherman AL, Chasten N, Epshteyn GG, Lee J, Helminen EC, Scheer JR. Brief transdiagnostic cognitive behavioral therapy and expressive writing for hazardous drinking and posttraumatic stress symptoms among sexual and gender minority adults: Pilot trial protocol. Contemp Clin Trials Commun. 2026 Jun 27;52:101666. doi: 10.1016/j.conctc.2026.101666. eCollection 2026 Aug.
- Individual participant dataSharing planned: No. Data from this study will not be shared due to the sensitive nature of the information collected and the pilot status of the project. Additionally, data sharing is not required by the study's funder.
Related trials for Alcohol Use Disorder (AUD)
RecruitingPhase 2
Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder
Major Depressive Disorder (MDD), Alcohol Use Disorder (AUD)
RecruitingPhase 1/2
Suvorexant for Alcohol Use Disorder (AUD): Neural Mechanisms
Healthy Volunteers, Alcohol Use Disorder (AUD)
Recruiting
High Intensity Alternating Current Stimulation as a Neuromodulation Therapy for Alcohol Use Disorder: A Pilot Study
Alcohol Use Disorder (AUD)
Not yet recruitingObservational study
Disease Intervention Specialist (DIS) for SUD
Substance Use Disorder (SUD), Opioid Use Disorder
RecruitingPhase 2
Suvorexant for Treatment of AUD and PTSD
Alcohol Use Disorder (AUD), Post Traumatic Stress Disorder (PTSD)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing CBT + expressive writing in people with Alcohol Use Disorder (AUD) and PTSD, run by University of Rhode Island at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 9 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Jillian Scheer, PhD (401-874-2193, jillian.scheer@uri.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Posttraumatic Stress Disorder Diagnosis and Severity using the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) (time frame: Baseline: Past 30 days 1-week Follow-up: Past 1 week). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07217795, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Dec 2025; AzTrials last refreshed its copy on 26 Oct 2026.